MSB 1.00% 99.0¢ mesoblast limited

Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events, page-22

  1. 313 Posts.
    lightbulb Created with Sketch. 343
    Patients overall. The trial is double blinded.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.